Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002455806 | SCV002740113 | uncertain significance | Cardiovascular phenotype | 2022-09-16 | criteria provided, single submitter | clinical testing | The p.V849I variant (also known as c.2545G>A), located in coding exon 16 of the SOS1 gene, results from a G to A substitution at nucleotide position 2545. The valine at codon 849 is replaced by isoleucine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV003101951 | SCV003261822 | likely benign | RASopathy | 2023-12-21 | criteria provided, single submitter | clinical testing |